Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Soochow UniversityActive in the last 2 years

Dapeng Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2861-3899; OpenAlex author ID A5100419606. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Multi-omics analyses inform mechanisms of immunotherapy response in pancreatic cancer. Co-author DOI 10.3389/fimmu.2025.1673098↗
  2. Efficacy of relative dose intensity of nab-paclitaxel for the short-term outcomes, survival, and quality of life in patients with advanced pancreatic cancer: a… Co-author DOI 10.21037/tcr-22-1604↗
  3. A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) plus Gemcitabine versus Gemcitabine in Patients with Advanced Pan… Last author DOI 10.7150/jca.15407↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jinming Cao · 1 shared paper, 2025 · strength 0.25
  2. Mengdan Xu · 1 shared paper, 2025 · strength 0.25
  3. Mengyao Wu · 1 shared paper, 2025 · strength 0.25
  4. Yecheng Li · 1 shared paper, 2025 · strength 0.25
  5. Kai Chen · 1 shared paper, 2025 · strength 0.25
  6. Ge Li · 1 shared paper, 2025 · strength 0.25
  7. Lian Lian · 1 shared paper, 2022 · strength 0.16
  8. Chong Zhou · 1 shared paper, 2022 · strength 0.16
  9. Lee Steven Schwartzberg · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.